Wolfe Research Downgrades T-Mobile US to Peer Perform
Wolfe Research analyst Peter Supino downgrades T-Mobile US (NASDAQ:TMUS) from Outperform to Peer Perform.
Exane BNP Paribas Downgrades Apple to Neutral, Announces $140 Price Target
Exane BNP Paribas analyst Jerome Ramel downgrades Apple (NASDAQ:AAPL) from Outperform to Neutral and announces $140 price target.
RBC Capital Downgrades Gilead Sciences to Sector Perform, Announces $87 Price Target
RBC Capital analyst Brian Abrahams downgrades Gilead Sciences (NASDAQ:GILD) from Outperform to Sector Perform and announces $87 price target.
Jefferies Downgrades Douglas Emmett to Underperform, Lowers Price Target to $13
Jefferies analyst Peter Abramowitz downgrades Douglas Emmett (NYSE:DEI) from Hold to Underperform and lowers the price target from $17 to $13.
Wells Fargo Downgrades Apellis Pharmaceuticals to Equal-Weight, Announces $58 Price Target
Wells Fargo analyst Derek Archila downgrades Apellis Pharmaceuticals (NASDAQ:APLS) from Overweight to Equal-Weight and announces $58 price target.
Jefferies Downgrades Invitation Homes to Hold, Lowers Price Target to $31
Jefferies analyst Linda Tsai downgrades Invitation Homes (NYSE:INVH) from Buy to Hold and lowers the price target from $38 to $31.
Jefferies Downgrades Independence Realty Trust to Hold, Lowers Price Target to $17
Jefferies analyst Linda Tsai downgrades Independence Realty Trust (NYSE:IRT) from Buy to Hold and lowers the price target from $20 to $17.
Keefe, Bruyette & Woods Downgrades Carlyle Group to Market Perform, Announces $36 Price Target
Keefe, Bruyette & Woods analyst Michael Brown downgrades Carlyle Group (NASDAQ:CG) from Outperform to Market Perform and announces $36 price target.
Jefferies Downgrades Life Storage to Hold, Lowers Price Target to $97
Jefferies analyst Jonathan Petersen downgrades Life Storage (NYSE:LSI) from Buy to Hold and lowers the price target from $123 to $97.
Jefferies Downgrades CubeSmart to Hold, Lowers Price Target to $41
Jefferies analyst Jonathan Petersen downgrades CubeSmart (NYSE:CUBE) from Buy to Hold and lowers the price target from $47 to $41.